Literature DB >> 35302362

Delivery Order of Nanoconstructs Affects Intracellular Trafficking by Endosomes.

Kwahun Lee1, Insub Jung1, Teri W Odom1.   

Abstract

This paper reports how the endosomal pathways of nanoparticle (NP) constructs with different surface curvatures are affected by their order of delivery. Sequential incubation of cytosine-phosphate-guanine (CpG)-conjugated spiky and spherical gold NPs with macrophages resulted in different nanoconstruct ratios at the interior edges of endosomes. Application of spiky NPs after spherical NPs accelerated the formation of late-stage endosomes and resulted in larger endosomes, and the spherical NPs were enclosed by the spiky NPs. In contrast, the reverse incubation order produced an asymmetric distribution of the two nanoconstruct shapes in smaller endosomes. Macrophages with a higher proportion of the enclosed spherical NPs as well as a larger ratio of spiky to spherical NPs at the endosomal edge showed enhanced toll-like receptor 9 activation and secretion of proinflammatory cytokines and chemokines. Our results indicate that the subcellular trafficking of targeting nanoconstructs by vesicles is affected by both the delivery order and the endosomal distribution. Our study also establishes a new approach for nanoscale monitoring of intracellular therapeutics delivery with conventional electron microscopy.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35302362      PMCID: PMC9344601          DOI: 10.1021/jacs.2c02276

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   16.383


  45 in total

1.  Remodeling of endosomes during lysosome biogenesis involves 'kiss and run' fusion events regulated by rab5.

Authors:  Sophie Duclos; Rachel Corsini; Michel Desjardins
Journal:  J Cell Sci       Date:  2003-03-01       Impact factor: 5.285

Review 2.  Endocytosis at the nanoscale.

Authors:  Irene Canton; Giuseppe Battaglia
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

3.  Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.

Authors:  Eric F Zhu; Shuning A Gai; Cary F Opel; Byron H Kwan; Rishi Surana; Martin C Mihm; Monique J Kauke; Kelly D Moynihan; Alessandro Angelini; Robert T Williams; Matthias T Stephan; Jacob S Kim; Michael B Yaffe; Darrell J Irvine; Louis M Weiner; Glenn Dranoff; K Dane Wittrup
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

4.  Rab conversion as a mechanism of progression from early to late endosomes.

Authors:  Jochen Rink; Eric Ghigo; Yannis Kalaidzidis; Marino Zerial
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

5.  Phagosome maturation and fusion with lysosomes in relation to surface property and size of the phagocytic particle.

Authors:  C de Chastellier; L Thilo
Journal:  Eur J Cell Biol       Date:  1997-09       Impact factor: 4.492

6.  Direct observation of nanoparticle-cancer cell nucleus interactions.

Authors:  Duncan Hieu M Dam; Jung Heon Lee; Patrick N Sisco; Dick T Co; Ming Zhang; Michael R Wasielewski; Teri W Odom
Journal:  ACS Nano       Date:  2012-03-22       Impact factor: 15.881

7.  Lysosomal Proton Buffering of Poly(ethylenimine) Measured In Situ by Fluorescent pH-Sensor Microcapsules.

Authors:  Sathi Roy; Dingcheng Zhu; Wolfgang J Parak; Neus Feliu
Journal:  ACS Nano       Date:  2020-06-29       Impact factor: 15.881

8.  Smaller CpG-Conjugated Gold Nanoconstructs Achieve Higher Targeting Specificity of Immune Activation.

Authors:  Jun Yue; Roger M Pallares; Lisa E Cole; Emma E Coughlin; Chad A Mirkin; Andrew Lee; Teri W Odom
Journal:  ACS Appl Mater Interfaces       Date:  2018-06-21       Impact factor: 9.229

9.  Organelle size control - increasing vacuole content activates SNAREs to augment organelle volume through homotypic fusion.

Authors:  Yann Desfougères; Heinz Neumann; Andreas Mayer
Journal:  J Cell Sci       Date:  2016-06-01       Impact factor: 5.285

10.  Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.

Authors:  Shu-Chen Liu; Ngan-Ming Tsang; Wen-Che Chiang; Kai-Ping Chang; Chuen Hsueh; Ying Liang; Jyh-Lyh Juang; Kai-Ping N Chow; Yu-Sun Chang
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.